Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Mar:47:64-71.
doi: 10.1016/j.cct.2015.12.009. Epub 2015 Dec 17.

Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors

Ruth E Patterson  1 , Catherine R Marinac  2 , Loki Natarajan  3 , Sheri J Hartman  3 , Lisa Cadmus-Bertram  4 , Shirley W Flatt  5 , Hongying Li  5 , Barbara Parker  5 , Jesica Oratowski-Coleman  5 , Adriana Villaseñor  3 , Suneeta Godbole  6 , Jacqueline Kerr  6
Affiliations
Randomized Controlled Trial

Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors

Ruth E Patterson et al. Contemp Clin Trials. 2016 Mar.

Abstract

Weight loss and metformin are hypothesized to improve breast cancer outcomes; however the joint impacts of these treatments have not been investigated. Reach for Health is a randomized trial using a 2 × 2 factorial design to investigate the effects of weight loss and metformin on biomarkers associated with breast cancer prognosis among overweight/obese postmenopausal breast cancer survivors. This paper describes the trial recruitment strategies, design, and baseline sample characteristics. Participants were randomized in equal numbers to (1) placebo, (2) metformin, (3) weight loss intervention and placebo, or (4) weight-loss intervention and metformin. The lifestyle intervention was a personalized, telephone-based program targeting a 7% weight-loss in the intervention arm. The metformin dose was 1500 mg/day. The duration of the intervention was 6 months. Main outcomes were biomarkers representing 3 metabolic systems putatively related to breast cancer mortality: glucoregulation, inflammation, and sex hormones. Between August 2011 and May 2015, we randomized 333 breast cancer survivors. Mass mailings from the California Cancer Registry were the most successful recruitment strategy with over 25,000 letters sent at a cost of $191 per randomized participant. At baseline, higher levels of obesity were significantly associated with worse sleep disturbance and impairment scores, lower levels of physical activity and higher levels of sedentary behavior, hypertension, hypercholesterolemia, and lower quality of life (p<0.05 for all). These results illustrate the health burden of obesity. Results of this trial will provide mechanistic data on biological pathways and circulating biomarkers associated with lifestyle and pharmacologic interventions to improve breast cancer prognosis.

Keywords: Breast cancer; Metformin; Survivorship; Trial; Weight loss.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Reach for Health CONSORT Diagram
See this image and copyright information in PMC

References

    1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2012. National Cancer Institute; Bethesda, MD: Apr, 2015. http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site.
    1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014 Feb 26;311(8):806–814. - PMC - PubMed
    1. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001 Nov;24(11):1936–1940. - PubMed
    1. Erickson K, Patterson RE, Flatt SW, et al. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2011 Jan 1;29(1):54–60. - PMC - PubMed
    1. Patterson RE, Cadmus LA, Emond JA, Pierce JP. Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas. 2010 May;66(1):5–15. - PubMed

Publication types

MeSH terms